Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-27

Clinical Trial Update: Cholecalciferol Supplementation Effect on Parathyroid Hormone in Hemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the effect of cholecalciferol supplementation on parathyroid hormone levels in hemodialysis patients with vitamin D deficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Cooperativa Asistencia Sindicato Médico Uruguay | Conditions: Vitamin D Deficiency, Hemodialysis Patient | Phase 4 | Status: COMPLETED